---
title: "InspireMD Appoints Peter Soukas As New Chief Medical Officer"
description: "InspireMD, Inc. has appointed Peter Soukas as Chief Medical Officer to enhance its carotid intervention tools. Soukas, who has extensive experience in vascular intervention, will continue his clinical"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/264035740.md"
published_at: "2025-11-03T13:18:59.000Z"
---

# InspireMD Appoints Peter Soukas As New Chief Medical Officer

> InspireMD, Inc. has appointed Peter Soukas as Chief Medical Officer to enhance its carotid intervention tools. Soukas, who has extensive experience in vascular intervention, will continue his clinical practice while leading the company's mission. He has been involved in over 24 carotid stenting trials and 150 endovascular trials, and is recognized for his research and relationships with key opinion leaders in the field.

InspireMD, Inc. (NSPR), developer of the CGuard Prime carotid stent system for the prevention of stroke, announced Monday the appointment of Peter Soukas as Chief Medical Officer to advance its mission to deliver best-in-class tools for carotid intervention.

Soukas brings significant experience and credentials in the field of vascular intervention to InspireMD. He serves as the Director of Vascular Medicine and the Peripheral Vascular Interventional Laboratory at The Miriam Hospital.

In addition to his role at InspireMD, Soukas will be maintaining his clinical practice.

Soukas has served as the site principal investigator on more than 24 trials in carotid stenting and the site principal investigator on more than 150 endovascular trials. He is a prolific researcher, publishing dozens of peer-reviewed papers with deep relationships among other key opinion leaders.

He is also board certified in cardiovascular disease, interventional cardiology, vascular medicine, and endovascular medicine, and is certified in noninvasive vascular lab interpretation.

For comments and feedback contact: editorial@rttnews.com

Business News

### Related Stocks

- [NSPR.US - InspireMD](https://longbridge.com/en/quote/NSPR.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| InspireMD Reports C-GUARDIANS Trial Shows Lowest Adverse Event Rates for Carotid Stenting | InspireMD Inc. announced the publication of results from its C-GUARDIANS pivotal trial in the Journal of the American Co | [Link](https://longbridge.com/en/news/272281694.md) |
| InspireMD (NYSE:NSPR) Insider Shane Thomas Gleason Sells 8,411 Shares | InspireMD insider Shane Thomas Gleason sold 8,411 shares at $1.57 each, totaling $13,205.27, reducing his stake by 0.72% | [Link](https://longbridge.com/en/news/274565328.md) |
| Envestnet Asset Management Inc. Cuts Stock Position in Edwards Lifesciences Corporation $EW | Envestnet Asset Management Inc. reduced its stake in Edwards Lifesciences Corporation by 23.1% in Q3, now holding 261,58 | [Link](https://longbridge.com/en/news/275999995.md) |
| 08:43 ETNorthwest Medical Arts Leads Kindness Initiative among Small Businesses | Northwest Medical Arts (NWMA) announces Random Acts of Kindness Week from February 14-21, 2026, encouraging community me | [Link](https://longbridge.com/en/news/275614746.md) |
| Avanti Capital Advances Impact-Driven Investing and Expands Commitment to Philanthropy | Avanti Capital, a multi-generational family office, is enhancing its impact-driven investing across various sectors, inc | [Link](https://longbridge.com/en/news/275701455.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.